CL2009000660A1 - Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain. - Google Patents
Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain.Info
- Publication number
- CL2009000660A1 CL2009000660A1 CL2009000660A CL2009000660A CL2009000660A1 CL 2009000660 A1 CL2009000660 A1 CL 2009000660A1 CL 2009000660 A CL2009000660 A CL 2009000660A CL 2009000660 A CL2009000660 A CL 2009000660A CL 2009000660 A1 CL2009000660 A1 CL 2009000660A1
- Authority
- CL
- Chile
- Prior art keywords
- par2
- antagonist
- protease
- inhibit
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Abstract
Uso de un antagonista del receptor 2 activado con proteasa (par2) para tratar, inhibir o aliviar el dolor.Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3790808P | 2008-03-19 | 2008-03-19 | |
US11915508P | 2008-12-02 | 2008-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009000660A1 true CL2009000660A1 (en) | 2010-04-16 |
Family
ID=40718925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009000660A CL2009000660A1 (en) | 2008-03-19 | 2009-03-18 | Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain. |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR070911A1 (en) |
CL (1) | CL2009000660A1 (en) |
PE (1) | PE20091693A1 (en) |
TW (1) | TW201002345A (en) |
UY (1) | UY31723A (en) |
WO (1) | WO2009117481A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11591389B2 (en) | 2017-03-16 | 2023-02-28 | Medimmune Limited | Nucleic acids encoding anti-PAR2 antibodies and uses thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214655B2 (en) * | 2001-05-21 | 2007-05-08 | Johnson & Johnson Consumer Companies, Inc. | Peptides and the use thereof in darkening the skin |
US7888482B2 (en) | 2006-02-10 | 2011-02-15 | Amgen Inc. | Antibodies that bind PAR-2 |
JO3246B1 (en) | 2009-09-09 | 2018-03-08 | Regeneron Pharma | High affinity human antibodies to human protease-activated receptor-2 |
AU2012331140A1 (en) | 2011-11-04 | 2014-05-08 | Lipotec, S.A. | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions |
EP3049418A1 (en) | 2013-09-25 | 2016-08-03 | Vertex Pharmaceuticals Incorporated | Imidazopyridazines useful as inhibitors of the par-2 signaling pathway |
US20160000791A1 (en) | 2014-07-07 | 2016-01-07 | Mayo Foundation For Medical Education And Research | Par1 modulation to alter myelination |
MX2018014135A (en) * | 2016-05-20 | 2019-06-17 | Takeda Pharmaceuticals Co | Treatment of pain. |
WO2017223427A1 (en) * | 2016-06-23 | 2017-12-28 | Mayo Foundation For Medical Education And Research | Par2 modulation to alter myelination |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629174A (en) * | 1993-07-26 | 1997-05-13 | Cor Therapeutics, Inc. | Recombinant C140 receptor |
KR19980701637A (en) * | 1995-01-25 | 1998-06-25 | 찰스 홈시 | Recombinant C14 receptor, its agonist and antagonist, and nucleic acid encoding the receptor |
US20090035315A1 (en) * | 2004-06-17 | 2009-02-05 | Stephan Christgau | Method of Improving Treatments in Rheumatic and Arthritic Diseases |
-
2009
- 2009-03-16 AR ARP090100937A patent/AR070911A1/en unknown
- 2009-03-17 PE PE2009000397A patent/PE20091693A1/en not_active Application Discontinuation
- 2009-03-18 WO PCT/US2009/037504 patent/WO2009117481A1/en active Application Filing
- 2009-03-18 CL CL2009000660A patent/CL2009000660A1/en unknown
- 2009-03-18 TW TW098108692A patent/TW201002345A/en unknown
- 2009-03-19 UY UY0001031723A patent/UY31723A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11591389B2 (en) | 2017-03-16 | 2023-02-28 | Medimmune Limited | Nucleic acids encoding anti-PAR2 antibodies and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
UY31723A (en) | 2009-11-10 |
TW201002345A (en) | 2010-01-16 |
WO2009117481A1 (en) | 2009-09-24 |
AR070911A1 (en) | 2010-05-12 |
PE20091693A1 (en) | 2009-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009000660A1 (en) | Use of a protease-activated receptor 2 (par2) antagonist to treat, inhibit, or relieve pain. | |
CR20110596A (en) | SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM | |
CL2008001114A1 (en) | Compounds derived from benzimidazole; pharmaceutical composition; and use in the treatment of diseases such as overactive bladder, pain, obesity, seizures, among others. | |
ECSP13012573A (en) | 6-amino-nicotinamides substituted as modulators of KCNQ2 / 3 | |
UY32085A (en) | KINASE INHIBITORS AND METHODS FOR USE | |
CR10309A (en) | "COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE ACTIVITY OF THE CANABINOID RECEIVER 1" | |
ECSP088874A (en) | USE OF FLIBANSERINE FOR THE TREATMENT OF SEXUAL DESIRE POSMENOPAUSIC DISORDERS | |
CO6400170A2 (en) | AGOSNISTS AND ANTAGONISTS OF THE S1P5 RECEIVER AND METHODS OF USE OF THE SAME | |
CY1115852T1 (en) | PHARMACEUTICAL COMPOSITIONS | |
ECSP11011127A (en) | ANTI-cMET NEW ANTIBODY | |
BR112013001613A2 (en) | tricyclic compounds and methods for making and using them. | |
CL2008000418A1 (en) | Use of an il-23 antagonist for the treatment of a fungal infection. | |
CL2008000202A1 (en) | Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain. | |
CL2011000544A1 (en) | Compounds derived from benzamide n substituted by heterocycle, cannabinoid receptor ligands; pharmaceutical composition; and its use to treat pain, among other diseases. | |
CR11264A (en) | COMPOUNDS OF 5- (4-HALO-ALCOXI) -PENYL) -PIRIMIDIN-2-AMINA AND COMPOSITIONS AS KINASE INHIBITORS | |
CL2015002534A1 (en) | Combined formulations of neosaxitoxin for prolonged local anesthesia | |
NI201000015A (en) | BUPROPION BROMHYDRATE AND THERAPEUTIC APPLICATIONS | |
EA201171074A1 (en) | CYTOTOXIC CONJUGATES WITH CONNECTION, BINDING THE NEUROPEPTIDE Y RECEPTOR | |
ECSP13012453A (en) | 2-oxy-quinoline-3-carboxamides substituted as KCNQ2 / 3 modulators | |
CL2007003251A1 (en) | Compounds derived from substituted 1H-pyrazoles, inhibitors of kinase-catalyzed reactions; its preparation procedure; pharmaceutical composition; intermediate compounds; use of the main compounds, useful in the treatment of cancer. | |
ECSP088939A (en) | CARBOXAMIDS REPLACED AS ANTAGONISTS OF THE METABOTROPIC RECEIVER OF GROUP I | |
CL2009001328A1 (en) | Compounds derived from 3-oxo-isoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder. | |
CL2008001296A1 (en) | Use of a npy y5 receptor antagonist for the treatment of a hypercortisolism-related disorder in a subject such as stress. | |
CL2015002188A1 (en) | Topical eye analgesic agents | |
CL2009001330A1 (en) | Compounds derived from cyano-3-oxoisoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder. |